EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Digital Twins: The Future Blueprint for Pharmaceutical Production
Digital Twins have revolutionized the pharmaceutical industry by providing virtual replicas of physical assets and processes This innovative technology offers a comprehensive view of manufacturing
Revolutionizing Healthcare: Gene Editing for Genetic Disorders with CRISPR Technology
Gene editing using CRISPR Clustered Regularly Interspaced Short Palindromic Repeats technology has the potential to revolutionize healthcare particularly in addressing genetic disorders
Smarter, Faster, Cheaper: The Quiet Revolution in Pharma's First Half of 2026
If you took a step back to look at the pharmaceutical industry during the first six months of one thing became obvious very quickly The old rules of global drug manufacturing were quietly rewritten For decades major lowcost production centers were viewed mostly as highvolume factories for basic
How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights
The pharmaceutical industry operates within a complex regulatory framework aimed at ensuring the safety efficacy and quality of medicinal products
B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority
The pharmaceutical industry has never been short of innovation Every year brings breakthroughs in biologics advanced therapies AIdriven drug discovery manufacturing automation precision medicine and digital health
Single-Use Technologies: Accelerating Flexible Biopharmaceutical Manufacturing
For most of the past two decades the case for singleuse technologies in biopharmaceutical manufacturing was argued in the language of the plant Disposable bags and flow paths removed cleaninplace and steaminplace loops shortened turnarounds and allowed engineers to stand up a suite without a validation campaign measured in seasons That argument has been won Disposable systems now appear at every s...
-
Techno Trends
UGA researchers develop oral drug candidate targeting drug-resistant malaria
Researchers from the University of Georgia UGA and the University of Illinois Chicago have developed a new oral antimalarial drug candidate that could help address drugresistant malaria
-
Projects
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Revolutionizing Healthcare: Gene Editing for Genetic Disorders with CRISPR Technology
Harry Callum
CRISPR technology, with its precision in gene editing, revolutionizes healthcare by enabling personalized treatments for genetic disorders. It’s potential for correcting mutations, therapeutic a...
-
2
Smarter, Faster, Cheaper: The Quiet Revolution in Pharma's First Half of 2026
Preeti Singh
The first half of 2026 marked a major shift in the pharmaceutical industry. Drugmakers proved they can produce complex medicines faster, cheaper, and at scale. Affordable biosimilars, GLP-1 therapies,...
-
3
How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights
Kate Williamson
This paper delves into how pharmacoepidemiology influences clinical research through innovative pharmaceutical packaging. It highlights regulatory challenges such as tamper-proofing, child-resistant p...
-
4
B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority
Kate Williamson
Decision-makers in the pharmaceutical industry rarely respond to promotional messaging alone. They look for evidence, expertise, and credible perspectives that help solve complex business and scientif...
-
5
Single-Use Technologies: Accelerating Flexible Biopharmaceutical Manufacturing
Lakshmi
Single-use technologies have moved from pilot-scale novelty to the default architecture of new biopharmaceutical capacity. This article examines what that maturity means for senior leadership: how dis...
press releases Read more...
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
ANI Pharmaceuticals Inc ANI or the Company Nasdaq ANIP today announced that it received final approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application
Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity
Wave Life Sciences Ltd Nasdaq WVE a clinicalstage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health today announced the initiation
INFORS HT Launches Multifors 3 bench-top bioreactor for process development
Multifors is what benchscale parallel bioprocessing should look like in Its built around a simple idea the bioreactor should capture and retain the information that matters so scientists can focus
Pretzel Therapeutics Receives FDA Fast Track Designation for PX578 for the Treatment of POLG-mediated Primary Mitochondrial Disorders
Pretzel Therapeutics Inc a clinicalstage biotechnology company advancing a new class of medicines designed to restore mitochondrial function improve cellular energetics and impede disease progression
Events Read more...
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
LATEST NEWS Read more...
Astoriom Acquires Additional UK Storage Business to Expand Capacity and Services
Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited the UK operations of life sciences stability storage provider Sampled based in Glasgow The acquisition expands
Variant Bio Expands Target Discovery Collaboration with Boehringer Ingelheim into Cardiovascular Disease
Variant Bio has expanded its multiyear research collaboration and licensing agreement with Boehringer Ingelheim to identify and validate new drug targets for cardiovascular disease
SK pharmteco and GEMMABio strengthen rare disease manufacturing collaboration
SK pharmteco has expanded its collaboration with clinicalstage gene therapy company GEMMABio to support the manufacture of materials for the companys Phase CHARISMA clinical trial for spinal muscular
Envisagenics and Boehringer Ingelheim enter multi-target collaboration for cancer therapi
Envisagenics has entered a multiyear research collaboration and option agreement with Boehringer Ingelheim to investigate tumourspecific targets for potential precision therapies for solid tumours
ExploRNA Therapeutics and Łukasiewicz - IChP partner on GMP manufacturing of mRNA cap analogue
ExploRNA Therapeutics has entered a strategic partnership with the ukasiewicz Research Network Industrial Chemistry Institute ukasiewicz IChP to advance the GMP manufacturing of its mRNA cap analogues
PTC Completes Acquisition of ST-920 Gene Therapy for Fabry Disease
PTC Therapeutics has completed its previously announced agreement with Sangamo Therapeutics to acquire ST isaralgagene civaparvovec a onetime AAV gene therapy candidate being developed for Fabry disease








